CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy

Clustered regularly interspaced short palindromic repeat-associated protein Cas9 (CRISPR/Cas9) technology is at the forefront of cancer immunotherapy innovation, offering precise and personalized treatment strategies. In this review, we discuss CRISPR/Cas9's ability to precisely edit the genome...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hyeseon Park (Autor), Yoo Kyung Kang (Autor), Gayong Shim (Autor)
Formato: Libro
Publicado: MDPI AG, 2024-03-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible